Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001104659-24-062806
Filing Date
2024-05-17
Accepted
2024-05-17 09:56:58
Documents
1
Effectiveness Date
2024-05-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11592
  Complete submission text file 0001104659-24-062806.txt   12891
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-513589 | Film No.: 24957994
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)